Tag Archives: antisense oligonucleotide therapy
FDA Grants Rare Pediatric Disease Designation to NS-050/NCNP-03 for Duchenne Muscular Dystrophy
FDA grants Rare Pediatric Disease Designation to NS-050/NCNP-03 for Duchenne muscular dystrophy (DMD). This promising.....Read more
05
Dec
Dec